NARA Discovery
Article Details
← Back to Search Results
Journal Article

Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification

A. Laroni; C. G. Giacomazzi; L. Grimaldi; P. Gallo; M. P. Sormani; A. Bertolotto; J. L. McDermott; I. Gandoglia; I. Martini; G. Vitello; F. Rinaldi; L. Barzon; V. Militello; M. Pizzorno; F. Bandini; E. Capello; G. Palù; A. Uccelli; G. L. Mancardi; O. E. Varnier
Journal of Neuroimmune Pharmacology · Vol. 7, Issue 3 · pp. 665-672 · 2012
View Full Text Download RIS Journal Homepage

Abstract

Abstract is unavailable.

Bibliographic Information

JournalJournal of Neuroimmune Pharmacology
PublisherSpringer
Publication Date2012-09-01
Publication Year2012
Volume7
Issue3
Pages665-672
Document TypeJournal Article
eISSN1557-1904
DOI10.1007/s11481-012-9366-z

Access Information

NARA Access Coverage2006-01-01~Current
Journal Homepagehttps://www.springer.com/journal/11481
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.